Repositorio Digital de la UPF
Publication
Artículo científico (JournalArticle)
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited impact on the identification of cancer predisposition genes (CPGs). Here we present a statistical method, ALFRED, that tests Knudson's two-hit hypothesis to systematically identify CPGs from cancer genome data. Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 - that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH). Rare germline variants in these genes contribute substantially to cancer risk, including to ~14% of ovarian carcinomas, ~7% of breast tumors, ~4% of uterine corpus endometrial carcinomas, and to a median of 2% of tumors across 17 cancer types., This work was supported by a European Research Council (ERC) Consolidator grant (616434), the AXA Research Fund, the Spanish Ministry of Economy and Competitiveness (BFU2011-26206 and ‘Centro de Excelencia Severo Ochoa 2013–2017’ SEV-2012-0208), the Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR), FP7 project 4DCellFate (277899), the EMBL-CRG Systems Biology Program and the CERCA Programme of the Generalitat de Catalunya. F.S. was also supported by FP7 grants MAESTRA (ICT-2013-612944) and InnoMol (FP7-REGPOT-2012-2013-1-316289). S.P. was funded by a Postdoctoral Fellowship from Novartis and by the Juan de la Cierva program (MINECO). The results published in this study are in part based upon data generated by The Cancer Genome Atlas project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at https://cancergenome.nih.gov/. We also acknowledge the 1000 genomes project, the Women’s Health Initiative, and UK10K as the sources of primary data.
Project:
EC / FP7 616434
,
ES / 3PN BFU2011-26206
,
EC / FP7 277899
,
EC / FP7 612944
,
EC / FP7 316289